The efficacy of Bromfenac sodium after intravitreal injection of Ranibizumab for age-related macular degeneratio
Not Applicable
- Conditions
- age-related macular degeneration
- Registration Number
- JPRN-UMIN000006573
- Lead Sponsor
- Yamagata University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
subjects with systemic risk factors
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method visual acuity, fundus examination including FA, IA and optical coherence tomography(OCT) , number of intravitreal injection
- Secondary Outcome Measures
Name Time Method